Key Deal Facts
Purpose: Provide consumers with a data-driven health software that provides better, more personalized recommendations.
Recurring Revenue: Predictable revenue stream from subscription sales model - $247 Lifetime Value of a Customer (LTV).
Large Margins & Scalable: High Avg Order Value of $179 - Low Cost of Goods Sold of ~$36 = $143 Gross Profit/Customer.
Proven Growth: 360% revenue growth from Q4 of 2019 to 2020 ($174,000 to $627,000). ~2M in total revenue in 2020.
Growth Potential: Digital health market will be worth $639B by 2026 & medical apps market size is growing at 23%/yr.
Highly Rated: 4.7 Trustpilot score, 98% retention rate, 64 NPS (Net Promoter Score) in Q4 and trending up.
Professional Experience: Team of 44 is composed of highly skilled scientists, MDs, PhDs, NDs and software engineers.
Operational Excellence: Bootstrapped to multimillion dollar revenue with only small seed investments (totaling $450K).
Management Team / Advisory Board Bios
Joseph Cohen, Founder, CEO
8+ years of professional executive experience in the health and biotech industry. Internationally recognized speaker and biohacker.
Growing up, I suffered from inflammation, brain fog, fatigue, digestive problems, anxiety, depression, & other issues that caused me to rack up medical bills. Finally, I started studying my genes and found solutions that actually worked to get rid of my health issues. I knew if personalized healthcare could work for me, it could work for others.
Puya Yazdi, Chief Scientific Officer
MD from USC, Resident Physician (Pathology) – Stanford University. Physician scientist with 15+ years of proven success in life sciences R&D, IP acquisition & science publications. Expertise in genomics, bioinformatics, biotech & nutraceuticals.